Lv1
50 积分 2022-04-20 加入
Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells
2个月前
已完结
Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells
2个月前
已关闭
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
2个月前
已完结
Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
2个月前
已完结
New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy
2个月前
已完结
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
2个月前
已完结
Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design
3个月前
已完结
Aldosterone synthase inhibition in chronic kidney disease
3个月前
已完结